Beijing, China

Songdong Meng

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Chinese Academy of Sciences. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Songdong Meng. Retrieved from https://idiyas.com/inventor/songdong-meng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Songdong Meng: Innovator in Hepatitis B Research

Introduction

Songdong Meng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical research, particularly in the development of therapeutic vaccines for hepatitis B. His innovative work has garnered attention in the scientific community.

Latest Patents

Songdong Meng holds a patent titled "Complex of hepatitis B virus-specific antigenic peptides associated with heat shock proteins and the application thereof." This invention provides a complex of HBV-antigen bound to heat shock proteins, which includes core antigen, surface antigen, and polymerase antigen. The complex can be utilized to prepare therapeutic vaccines aimed at treating hepatitis B and primary hepatocellular carcinoma. He has 1 patent to his name.

Career Highlights

Meng is affiliated with the Chinese Academy of Sciences, where he conducts his research. His work focuses on the intersection of virology and immunology, contributing to advancements in vaccine development.

Collaborations

Some of his notable coworkers include Bo Tian and George Fu Gao. Their collaborative efforts have furthered research in the field of hepatitis B and related therapies.

Conclusion

Songdong Meng's innovative contributions to hepatitis B research highlight his role as a key inventor in the medical field. His work continues to pave the way for advancements in therapeutic vaccines.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…